Grants to USA, Canada, and International investigators for research studies focused on epilepsy. Interested applicants are required to submit a letter of intent prior to the full proposal. Funding is intended to support transformative projects by established and early-career researchers that address prevention, elimination, and disease modification.
The CURE Epilepsy Award reflects CURE Epilepsy’s continued focus on scientific advances that have the potential to truly transform the lives of those affected by epilepsy, with prevention and disease modification as critical goals. Key priority areas for the award include: 1) Basic mechanisms of epilepsy; 2) Acquired epilepsies; 3) Pediatric epilepsies; 4) SUDEP; 5) Treatment-resistant epilepsies; and 6) Sleep & epilepsy.
CURE Epilepsy encourages applications from groups underrepresented in the biomedical, clinical, behavioral, and social sciences. These groups include individuals with disabilities, veterans, persons from underrepresented racial and ethnic groups and gender diverse groups, women in biomedical-related disciplines, or any legally protected characteristic.
The following priority areas reflect CURE Epilepsy’s focus on advances that have the potential to truly transform and save lives:
- Transformative research to enhance understanding of the cellular, molecular, genetic, and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies.
- Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy. Examples include epilepsy that develops after stroke, tumor, traumatic brain injury or infection, including febrile infection-related epilepsy syndrome (FIRES) as well as new-onset refractory status-epilepticus (NORSE).
- Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies.
- Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant.
- Novel research that furthers understanding of the causes and ultimate elimination of SUDEP.
- Translational, clinical, and clinically informed basic research that will facilitate understanding of the cellular-, molecular-, and systems-level mechanisms that underlie the relationships between sleep and epilepsy.
Funding requests may include salary support for the Principal Investigator (PI), co-PIs, technical staff, supplies, animal costs, publication fees and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research. Limited equipment purchases that are required to complete goals will be considered.
For additional information, see: https://www.cureepilepsy.org/wp-content/uploads/2023/11/2024-CURE-Epilepsy-Award-LOI-and-Full-Proposal-Guidelines_Final.pdf#page=12